Literature DB >> 22760822

Mutagenic analysis in a pure molecular system shows that thioredoxin-interacting protein residue Cys247 is necessary and sufficient for a mixed disulfide formation with thioredoxin.

Benjamin Fould1, Véronique Lamamy, Sophie-Penelope Guenin, Christine Ouvry, Francis Cogé, Jean A Boutin, Gilles Ferry.   

Abstract

The human thioredoxin (TRX)-interacting protein is found in multiple subcellular compartments and plays a major role in redox homeostasis, particularly in the context of metabolism (e.g., lipidemia and glycemia) and apoptosis. A molecular approach to the protein's modus operandi is still needed because some aspects of the TRX-interacting protein-mediated regulation of TRX are not clearly understood. To this end, His-tagged TRX-interacting proteins were over-expressed in Escherichia coli. Because the protein is expressed mainly in inclusion bodies, it was denatured in high concentrations of guanidium hydrochloride, centrifuged, and purified by Ni-NTA affinity chromatography. His-TRX-interacting protein was then refolded by dialysis and its restructuring monitored by circular dichroism spectrometry. This preparation resulted in the formation of a covalent complex with recombinant human TRX, demonstrating that association occurs without the intervention of other partner proteins. Multiple cysteine-to-serine mutants of TRX-interacting protein were produced and purified. These mutations were efficient in limiting the formation of disulfide-linked homo-oligomers in an oxidizing environment. The mutants were also used to gain functional insight into the formation of the TRX-interacting protein-TRX complexes. These complexes were able to form in the absence of internal disulfide bridges. A mutant with all but one cysteine changed to serine (Cys ²⁴⁷) also showed an enhanced capacity to form complexes with TRX demonstrating, in a pure molecular system, that this particular cysteine is likely responsible for the disulfide bridge between TRX-interacting protein and TRX.
Copyright © 2012 The Protein Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22760822      PMCID: PMC3631361          DOI: 10.1002/pro.2119

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  24 in total

Review 1.  Review: a structural view of the GroE chaperone cycle.

Authors:  H Grallert; J Buchner
Journal:  J Struct Biol       Date:  2001-08       Impact factor: 2.867

2.  Thioredoxin-interacting protein mediates TRX1 translocation to the plasma membrane in response to tumor necrosis factor-α: a key mechanism for vascular endothelial growth factor receptor-2 transactivation by reactive oxygen species.

Authors:  Cameron World; Oded N Spindel; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-02       Impact factor: 8.311

3.  Thioredoxin regulates adipogenesis through thioredoxin-interacting protein (Txnip) protein stability.

Authors:  William A Chutkow; Richard T Lee
Journal:  J Biol Chem       Date:  2011-06-24       Impact factor: 5.157

Review 4.  Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2.

Authors:  Rie Watanabe; Hajime Nakamura; Hiroshi Masutani; Junji Yodoi
Journal:  Pharmacol Ther       Date:  2010-05-08       Impact factor: 12.310

5.  Nutrient-sensing hypothalamic TXNIP links nutrient excess to energy imbalance in mice.

Authors:  Clémence Blouet; Gary J Schwartz
Journal:  J Neurosci       Date:  2011-04-20       Impact factor: 6.167

6.  Thioredoxin-interacting protein (Txnip) is a critical regulator of hepatic glucose production.

Authors:  William A Chutkow; Parth Patwari; Jun Yoshioka; Richard T Lee
Journal:  J Biol Chem       Date:  2007-11-12       Impact factor: 5.157

7.  Site-directed mutagenesis of active site cysteines in human thioredoxin produces competitive inhibitors of human thioredoxin reductase and elimination of mitogenic properties of thioredoxin.

Authors:  J E Oblong; M Berggren; P Y Gasdaska; G Powis
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

Review 8.  Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome.

Authors:  Ahsan M Kaimul; Hajime Nakamura; Hiroshi Masutani; Junji Yodoi
Journal:  Free Radic Biol Med       Date:  2007-06-06       Impact factor: 7.376

9.  The molecular pathway for the regulation of phosphoribulokinase by thioredoxin f.

Authors:  H K Brandes; F W Larimer; F C Hartman
Journal:  J Biol Chem       Date:  1996-02-16       Impact factor: 5.157

10.  The arrestin fold: variations on a theme.

Authors:  Laurence Aubry; Dorian Guetta; Gérard Klein
Journal:  Curr Genomics       Date:  2009-04       Impact factor: 2.236

View more
  2 in total

1.  W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway.

Authors:  Ting Li; Guang-Yao Lin; Li Zhong; Yan Zhou; Jia Wang; Yue Zhu; Yang Feng; Xiao-Qing Cai; Qing Liu; Olivier Nosjean; Jean A Boutin; Pierre Renard; De-Hua Yang; Ming-Wei Wang
Journal:  Acta Pharmacol Sin       Date:  2017-05-15       Impact factor: 6.150

2.  Further assessments of ligase LplA-mediated modifications of proteins in vitro and in cellulo.

Authors:  Alicia Schirer; Anne Rouch; Estelle Marcheteau; Johann Stojko; Elodie Jeantet; Benjamin Fould; Gilles Ferry; Jean A Boutin
Journal:  Mol Biol Rep       Date:  2021-10-31       Impact factor: 2.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.